ArticleBMC sports science, medicine & rehabilitation2026
Individualized exercise intervention for the overweight and obese population using WeChat and wearable devices: a non-randomized trial.
Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo determine the efficacy of an individualized exercise plan based on WeChat and wearable device monitoring among the overweight and obese population.
methodsOne hundred thirty patients who were diagnosed as obese or overweight were included and grouped based on voluntary registration between January 2022 and December 2023. The remote WeChat exercise management model with wearable device monitoring was applied to patients in the study group (n = 92) for 3 months. The control group (n = 38) received an exercise prescription at the time of enrollment and a single education session on sports-related knowledge. Then, the patients in the control group were required to undergo self-exercise and -management for 3 months.
resultsThere were significant improvements in weight, body mass index (BMI), waist circumference, hip circumference, blood pressure, body fat, body fat percentage, visceral fat area, and HOMA-IR, as well as total cholesterol, low-density lipoprotein-cholesterol, fasting blood glucose, and fasting insulin levels in the study group after intervention compared to before intervention. The changes in the control group after intervention were not significantly different than before intervention. After adjustment of the baseline differences based on covariance analysis, the following indicators were shown to have statistically significant better improvement in the study group than those the control group after intervention: decreased weight, BMI, waist circumference, hip circumference, body fat, and visceral fat area; lower total cholesterol and low-density lipoprotein-cholesterol levels; and improved glycated hemoglobin concentration. Performance was superior in the study group compared to the control group).
conclusionAn individualized exercise prescription intervention plan may be conducive to weight loss, fat reduction, lowering blood pressure and blood lipid levels, and improvement in glucose metabolism among the overweight and obese population.
trial registrationThe clinical trial registration number: ChiCTR2100046307, registered on 12 May 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.